SCHEMBL4819345

SCHEMBL4819345

CC(=O)OCCc1ccc(C(C)=O)cc1Cl

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 1/20 0.41
ALDH1A1 P00352 5/20 0.41
MAPK1 P28482 2/20 0.41
ADRB2 P07550 1/20 0.40
MRGPRX4 Q96LA9 1/20 0.39
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
PKM P14618 1/20 0.39
MAPT P10636 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
L3MBTL1 Q9Y468 3/20 0.38
GAA P10253 2/20 0.38
POLB P06746 1/20 0.38
HPGD P15428 1/20 0.37
ESRRA P11474 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27949329 0.84 HPGD (0.50) SIRT2ALDH1A1LMNAHTTL3MBTL1
SCHEMBL27728433 0.81 CHRM2 (0.44) SIRT2ALDH1A1MAOAMAPTMEN1
SCHEMBL4810977 0.80 PKM (0.47) ALDH1A1MAPK1ADRB2MRGPRX4MAOA
SCHEMBL27974256 0.80 POLB (0.43) ALDH1A1MAOAMAPTMEN1KMT2A
SCHEMBL10477756 0.79 PKM (0.60) ALDH1A1PKMMEN1KMT2AHTT
SCHEMBL16728864 0.78 TAS1R3 (0.49) ALDH1A1MAPK1ADRB2MRGPRX4MAOA
SCHEMBL10499879 0.77 MAOA (0.46) SIRT2ALDH1A1MAOAMAOBMAPT
SCHEMBL30665778 0.76 CYP2D6 (0.42) ALDH1A1MAPK1ADRB2MRGPRX4MAOA
SCHEMBL17831661 0.76 CYP2D6 (0.42) ALDH1A1MAPK1ADRB2MRGPRX4MAOA
SCHEMBL15492066 0.75 PKM (0.44) ALDH1A1MAPK1ADRB2MRGPRX4MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7468364-B2 Carbapenem compounds DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2008-12-23 US disclosed
US-7468364-B2 Carbapenem compounds DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2008-12-23 US disclosed
US-7468364-B2 Carbapenem compounds DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2008-12-23 US disclosed
US-20060183730-A1 Novel carbapenem compounds DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2006-08-17 US disclosed
EP-1612211-A1 NOVEL CARBAPENEM COMPOUNDS SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2006-01-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060183730-A1 Novel carbapenem compounds MGAM, SI, MCRS1 SIRT2 1457/4885ALDH1A1 1294/4885MAPK1 2527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.